ECP 2018 Final Programme

Wednesday, 12 Sept 112 ECP 2018 · Bilbao Poster Presentations a Wednesday PS-20 015 Alteration of claudin and microRNA expression in patients with both primary and metastatic colorectal cancer János Karczub, Hungary E. Kontsek, B. Gyöngyösi, Z. Krámer, G. Lendvai, Z. Schaff, A. Kiss 016 Correlation of mismatch repair pro- teins/microsatellite instability status with PDL1 expression in poorly differentiated colorectal carcinoma Ladan Fazlollahi, USA P. Dalerba, H. Remotti 017 Presence of a high amount of stroma within BRAF-mutated colon cancer predicts for very poor survival Gabi van Pelt, The Netherlands A. Huijbers, E. Domingo, R. Kerr, E. Johnstone, I. Tomlinson, D. Kerr, R. Tollenaar, W. E. Mesker 018 Ulcerative colitis and lymphomas – a lethal combination with forerunner changes Cristiana Popp, Romania F. Staniceanu, G. Micu, B. Mateescu, B. Mastalier, B. Harsan, A. Ienea, M. Cioplea, A. Bengus, M. Marinescu 020 Lymph node size is prognostic in node-positive colon cancer Bruno Märkl, Germany B. Martin, M. Anthuber, G. Schenkirsch, P. Schrembs 023 Tumour budding is predictive for lymph node metastasis and survival in patients with pT1b oesophageal adenocarcinoma Katharina Biermann, The Netherlands F. ten Kate, L. Looijenga 024 Standardising classification of PMP does not warrant standard interpretation: identifying the problem areas Marie-Louise van Velthuysen, The Netherlands N. Carr, F. Bibeau, R. Bradley, P. Dartigues, K. Geisinger, G. Xianyong, S. Isaac, J. Misdraji, R. Pai, J. Shia, M. Taggart, R. Yantiss 025 Lymphovascular invasion diagnostic rate variation and predictors assessed in 1,303 colorectal resections Michael Bonert, Canada H. Kazerouni, S. Al-Haddad, P. Major, A. Naqvi 026 PD-L1 expression in EBV-negative gastric adenocarcinoma and clinicopathological analysis Yao Fu, People's Republic of China Q. Shi, H. Wu, X. Fan 027 The correlation and upregulation of PD-L1 and CMTM6 in EB virus-associated gastric cancer Yao Fu, People's Republic of China H. Wu, Q. Shi, X. Fan 028 Hyperplastic polyp subtypes; morphomo- lecular study Sulen Sarioglu, Turkey E. Uzun, O. Sagol, M. Unlu 029 Characterising soluble E-cadherin and HER2 molecules compared to immunohis- tochemical expression in metastatic gastric cancer Vincenzo Canzonieri, Italy G. Miolo, A. Steffan, T. Perin, L. Alessandrini, L. Memeo, R. Cannizzaro, V. De Re 030 Nuclear Farnesoid X Receptor expression as indicator of progressive disease and poor prognosis for colorectal cancer patients Stamatios Theocharis, Greece I. Kostakis, C. Mihailidou, E. Danas, A. Koutava, M. Karamouzis, G. Kouraklis, G. Tsourouflis